Lanchi Ventures leads $42m Series A round for Chinese biotech startup Allink 2024-11-28T18:55:49-05:00November 28th, 2024| share this article![#item_full_content] Read More share this article! Related Posts VW on track to streamline China operations with Xinjiang plant sale November 28th, 2024 New World sells Hong Kong sports park stake to parent to tackle debt November 28th, 2024 Opinion | Trump tariffs could be a blessing in disguise for China’s reformers November 28th, 2024 Korean Air-Asiana merger to move ahead after EU review ends November 28th, 2024
